or Try an Advanced Search...

    Blood Cells Stocks List

    Symbol Grade Name % Change
    TEVA B Teva Pharmaceutical Industries 0.72
    AMGN B Amgen Inc. 0.37
    FATE D Fate Therapeutics, Inc. 0.24
    CERS D Cerus Corporation 2.33
    RCKT F Rocket Pharmaceuticals, Inc. 1.07
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Red Blood Cell Biotechnology Medicine Bone Drugs Hematology Pharmaceutical Products Platelet Active Pharmaceutical Ingredients Adult Stem Cell Allergy Anemia Asthma Biology Biopharmaceutical Birth Control Blood Blood Products Blood Transfusion Bone Disease

    Related ETFs - A few ETFs which own one or more of the above listed Blood Cells stocks.

    Symbol Grade Name Weight
    BBH D Market Vectors Biotech ETF 15.08
    IBBQ C Invesco Nasdaq Biotechnology ETF 8.93
    IBB C iShares Nasdaq Biotechnology Index Fund 8.88
    ISRA C Market Vectors Israel ETF 8.54
    BIS B ProShares UltraShort Nasdaq Biotechnology 8.37
    View all Blood Cells ETFs...
    Compare ETFs
    Compare BBH to BIS Compare BBH to ISRA Compare IBBQ to BIS

        Blood Cells Stocks Recent News

        Date Stock Title
        May 2 TEVA Teva’s 2023 Healthy Future Report Showcases Renewed Sustainability Strategy and Ambitious Targets
        May 2 TEVA Q1 2024 Corcept Therapeutics Inc Earnings Call
        May 2 AMGN Nasdaq, S&P 500 Futures Rise Ahead Of Apple Earnings: Why This Analyst Thinks 'No Cut' Scenario May Not Be Negative For Market
        May 2 TEVA Corcept Therapeutics Inc (CORT) Q1 2024 Earnings Call Transcript Highlights: Strong Growth Amid ...
        May 1 CERS Cerus Q1 2024 Earnings Preview
        May 1 AMGN Amgen Stock: Recent Weakness Is Not A Buying Opportunity Yet
        May 1 AMGN Amgen Q1 Earnings Preview: Obesity treatment updates to be the focus this season
        May 1 AMGN CytomX surges on upcoming data for Amgen-partnered cancer drug
        May 1 AMGN Amgen investors await weight-loss drug data
        May 1 AMGN AMGEN HIGHLIGHTS NEW COPD, ASTHMA AND VASCULITIS RESEARCH AT ATS 2024
        Apr 30 AMGN Sandoz Settles Patent Dispute With Amgen Related To Bone Disorder Drug Denosumab
        Apr 30 TEVA Novo, Teva, AstraZeneca issued FTC warnings over ‘bogus’ patents
        Apr 30 RCKT Rocket Pharmaceuticals (RCKT) Upgraded to Buy: Here's Why
        Apr 30 AMGN Will These 5 Drug/Biotech Stocks Beat Q1 Earnings Forecast?
        Apr 30 TEVA U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-Free Interchangeable Biosimilar to Humira® (adalimumab)
        Apr 30 AMGN Sandoz, Amgen reach agreement resolving patent litigation over biosimilars
        Apr 30 AMGN Sandoz reaches agreement with Amgen over patent dispute
        Apr 29 FATE Fate Therapeutics: As Its Rally Fizzles, We May Be Near The Bottom
        Apr 29 AMGN AMGEN ANNOUNCES WEBCAST OF 2024 FIRST QUARTER FINANCIAL RESULTS
        Apr 29 AMGN Amgen court hearing in patent lawsuit vs Sandoz over generic Prolia cancelled (update)
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Red Blood Cell Biotechnology Medicine Bone Drugs Hematology Pharmaceutical Products Platelet Active Pharmaceutical Ingredients Adult Stem Cell Allergy Anemia Asthma Biology Biopharmaceutical Birth Control Blood Blood Products Blood Transfusion Bone Disease
        Blood Cells

        A blood cell, also called a hematopoietic cell, hemocyte, or hematocyte, is a cell produced through hematopoiesis and found mainly in the blood. Major types of blood cells include red blood cells (erythrocytes), white blood cells (leukocytes), and platelets (thrombocytes). Together, these three kinds of blood cells add up to a total 45% of the blood tissue by volume, with the remaining 55% of the volume composed of plasma, the liquid component of blood.

        More about Blood Cells
        Browse All Tags